Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I JACOBSON

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
The Journal of Peptide Research : Official Journal of the American Peptide Society|May 14, 2004
Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimizationL A DeFreest, F B Mesfin, L Joseph, et al.
The Lancet. Oncology|May 31, 2024
Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health systemAlex K Bryant, Jacqueline R Lewy, R Daniel Bressler, et al.
Journal of Pharmacological and Toxicological Methods|March 28, 2006
Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HTM H Bridgland-Taylor, A C Hargreaves, A Easter, et al.
Frontiers in Neuroscience|December 17, 2025
GABAergic neurons are a key cell type in a <i>Drosophila</i> model of PARK14/<i>PLA2G6</i>-associated neurodegenerationNoah S Meimoun, Shimshon Benji, William Z Besharim, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
The Journal of Peptide Research : Official Journal of the American Peptide Society|May 14, 2004
Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimizationL A DeFreest, F B Mesfin, L Joseph, et al.
The Lancet. Oncology|May 31, 2024
Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health systemAlex K Bryant, Jacqueline R Lewy, R Daniel Bressler, et al.
Journal of Pharmacological and Toxicological Methods|March 28, 2006
Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HTM H Bridgland-Taylor, A C Hargreaves, A Easter, et al.
Frontiers in Neuroscience|December 17, 2025
GABAergic neurons are a key cell type in a <i>Drosophila</i> model of PARK14/<i>PLA2G6</i>-associated neurodegenerationNoah S Meimoun, Shimshon Benji, William Z Besharim, et al.
Pageof 14